Leukemia Research Foundation Inc is located in Northfield, IL. The organization was established in 1954. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 06/2022, Leukemia Research Foundation Inc employed 8 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Leukemia Research Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Leukemia Research Foundation Inc generated $2.9m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 6.2% each year. All expenses for the organization totaled $2.5m during the year ending 06/2022. While expenses have increased by 3.4% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Leukemia Research Foundation Inc has awarded 59 individual grants totaling $6,555,808. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE LEUKEMIA RESEARCH FOUNDATION IS DEDICATED TO CONQUERING ALL BLOOD CANCERS BY FUNDING RESEARCH INTO THEIR CAUSES AND CURES, AND ENRICHING THE QUALITY OF LIFE OF THOSE TOUCHED BY THESE DISEASES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
WE FUND PROMISING RESEARCH WORLDWIDE TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS AND THERAPIES FOR ALL BLOOD CANCERS, INCLUDING LEUKEMIA, LYMPHOMA, MYELOMA, AND MYELODYSPLASTIC SYNDROMES. OUR RESEARCHERS' PROJECTS IN GENOMICS, IMMUNOTHERAPIES, AND STEM CELL BIOLOGY HAVE ADVANCED OUR UNDERSTANDING OF WHAT DRIVES THESE CANCERS TO FORM AND PROGRESS AND WHAT BIOLOGICAL MARKERS COULD BE TARGETS FOR TREATMENT. IN FY2022, WE AWARDED THIRTEEN $100,000 GRANTS TO RESEARCHERS WORLDWIDE. IN ADDITION TO SUPPORTING RESEARCH THROUGH OUR NEW INVESTIGATOR RESEARCH GRANT PROGRAM, WE ARE PARTNERING WITH CURES WITHIN REACH THIS YEAR TO FUND A $75,000 DRUG REPURPOSING CLINICAL TRIAL FOR BLOOD CANCERS. THE CLINICAL TRIAL WILL LEVERAGE THE SPEED, SAFETY, AND COST-EFFECTIVENESS OF TESTING A THERAPY ALREADY APPROVED BY THE FDA TO DELIVER A NEW EFFECTIVE TREATMENT TO PATIENTS MORE QUICKLY.
OUR NEED-BASED PATIENT GRANT PROGRAM IS INTENDED TO ASSIST PATIENTS AND THEIR FAMILIES BY EASING THE FINANCIAL BURDEN SO THEY CAN FOCUS ON THEIR HEALTH AND TREATMENT. ELIGIBLE PATIENTS WITH LEUKEMIA, LYMPHOMA, MYELOMA, OR MYELODYSPLASTIC SYNDROME CAN RECEIVE A ONE-TIME GRANT OF UP TO $1,500. IN FY2022, WE DISPERSED GRANTS TO 102 PATIENTS.
THROUGH OUR FREE EDUCATION CONFERENCES AND WEBINARS, PATIENTS AND THEIR LOVED ONES CAN LEARN ABOUT VARIOUS BLOOD CANCER-RELATED TOPICS AND SPEAK WITH EXPERT HEMATOLOGY/ONCOLOGY PHYSICIANS. IN FY2022, APPROXIMATELY 971 PEOPLE REGISTERED FOR OUR EDUCATION PROGRAMS.WE ALSO OFFER FREE PEER SUPPORT SERVICES TO BLOOD CANCER PATIENTS AND CAREGIVERS, INCLUDING AN ONLINE SUPPORT COMMUNITY, AND PARTNER WITH A CANCER SUPPORT ORGANIZATION TO PROVIDE A PEER MENTORING PROGRAM. IN FY2022, MORE THAN 4,000 PEOPLE PARTICIPATED IN OUR PEER SUPPORT PROGRAMS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Kevin Radelet Executive Director | Officer | 37.5 | $132,087 |
Blake Brandwein President | OfficerTrustee | 0.5 | $0 |
Gerald Brin Treasurer | OfficerTrustee | 0.5 | $0 |
Patty Mix Secretary | OfficerTrustee | 0.5 | $0 |
Harvey Brin At Large Member | Trustee | 0.5 | $0 |
Robert Grabemann General Counsel | Trustee | 0.5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $58,076 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $2,865,917 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,923,993 |
Total Program Service Revenue | $0 |
Investment income | $6,619 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$20,438 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,910,174 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,068,340 |
Grants and other assistance to domestic individuals. | $147,478 |
Grants and other assistance to Foreign Orgs/Individuals | $296,255 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $150,781 |
Compensation of current officers, directors, key employees. | $36,768 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $487,214 |
Pension plan accruals and contributions | $8,432 |
Other employee benefits | $61,637 |
Payroll taxes | $48,056 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $21,291 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $8,299 |
Advertising and promotion | $728 |
Office expenses | $33,815 |
Information technology | $29,192 |
Royalties | $0 |
Occupancy | $67,442 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $15,746 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $1,125 |
Insurance | $4,059 |
All other expenses | $1,271 |
Total functional expenses | $2,501,059 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,275,860 |
Savings and temporary cash investments | $450,762 |
Pledges and grants receivable | $385,386 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $9,616 |
Net Land, buildings, and equipment | $593 |
Investments—publicly traded securities | $2,533,606 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $379,251 |
Total assets | $5,035,074 |
Accounts payable and accrued expenses | $77,850 |
Grants payable | $1,504,595 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $1,582,445 |
Net assets without donor restrictions | $2,992,515 |
Net assets with donor restrictions | $460,114 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $5,035,074 |
Over the last fiscal year, Leukemia Research Foundation Inc has awarded $1,068,340 in support to 11 organizations.
Grant Recipient | Amount |
---|---|
Philadelphia, PA PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Somerville, MA PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
New York, NY PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Saint Louis, MO PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Los Angeles, CA PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Over the last fiscal year, we have identified 56 grants that Leukemia Research Foundation Inc has recieved totaling $611,079.
Awarding Organization | Amount |
---|---|
William R Rich Foundation Rosemont, IL PURPOSE: SUPPORT | $150,000 |
The Bessemer Giving Fund Woodbridge, NJ PURPOSE: GENERAL SUPPORT | $70,000 |
Nikoh Foundation Northbrook, IL PURPOSE: CANCER RESEARCH. | $50,000 |
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $47,495 |
Cole-Crone Family Foundation Inc Deerfield, IL PURPOSE: UNRESTRICTED | $25,000 |
Chc Creating Healthier Communities Alexandria, VA PURPOSE: RESEARCH/PUBLICEDUCATION | $19,996 |
Beg. Balance | $85,360 |
Earnings | $305 |
Other Expense | $139 |
Ending Balance | $85,526 |
Organization Name | Assets | Revenue |
---|---|---|
Lungevity Foundation Chicago, IL | $12,082,053 | $14,543,433 |
Pkd Foundation Kansas City, MO | $20,909,832 | $16,124,449 |
Citizens United For Research In Epilepsy Chicago, IL | $10,496,452 | $6,043,691 |
Omega Medical Grants Association Rosemont, IL | $5,080,670 | $4,530,118 |
American Medical Association Foundation Chicago, IL | $26,650,564 | $8,763,967 |
Leukemia Research Foundation Inc Northfield, IL | $5,035,074 | $2,910,174 |
Head For The Cure Kansas City, MO | $719,180 | $1,965,362 |
Levelup Kids Inc Kansas City, MO | $1,600,938 | $1,601,663 |
Partnership For Cures Chicago, IL | $2,901,397 | $2,128,264 |
Orthopaedic Foot & Ankle Foundation Rosemont, IL | $10,882,425 | $1,439,579 |
Bryon Riesch Paralysis Foundation Inc Waukesha, WI | $477,065 | $417,057 |
St Louis Life Sciences Project St Louis, MO | $288,211 | $470,000 |